Literature DB >> 25421756

Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.

K Åkesson1, A Tompa, A Rydén, M Faresjö.   

Abstract

Type 1 diabetes (T1D) and coeliac disease are both characterized by an autoimmune feature. As T1D and coeliac disease share the same risk genes, patients risk subsequently developing the other disease. This study aimed to investigate the expression of T helper (Th), T cytotoxic (Tc) and regulatory T cells (Treg ) in T1D and/or coeliac disease children in comparison to healthy children. Subgroups of T cells (Th : CD4(+) or Tc : CD8(+) ); naive (CD27(+) CD28(+) CD45RA(+) CCR7(+) ), central memory (CD27(+) CD28(+) CD45RA(-) CCR7(+) ), effector memory (early differentiated; CD27(+) CD28(+) CD45RA(-) CCR7(-) and late differentiated; CD27(-) CD28(-) CD45RA(-) CCR7(-) ), terminally differentiated effector cells (TEMRA; CD27(-) CD28(-) CD45RA(+) CCR7(-) ) and Treg (CD4(+) CD25(+) FOXP3(+) CD127(-) ) cells, and their expression of CD39, CD45RA, CD101 and CD129, were studied by flow cytometry in T1D and/or coeliac disease children or without any of these diseases (reference group). Children diagnosed with both T1D and coeliac disease showed a higher percentage of TEMRA CD4(+) cells (P < 0·05), but lower percentages of both early and late effector memory CD8(+) cells (P < 0·05) compared to references. Children with exclusively T1D had lower median fluorescence intensity (MFI) of forkhead box protein 3 (FoxP3) (P < 0·05) and also a lower percentage of CD39(+) and CD45RA(+) within the Treg population (CD4(+) CD25(+) FOXP3(+) CD127(-) ) (P < 0·05). Children with exclusively coeliac disease had a higher MFI of CD101 (P < 0·01), as well as a higher percentage of CD129(+) (P < 0·05), in the CD4(+) CD25(hi) lymphocyte population, compared to references. In conclusion, children with combined T1D and coeliac disease have a higher percentage of differentiated CD4(+) cells compared to CD8(+) cells. T1D children show signs of low CD39(+) /CD45RA(+) Treg cells that may indicate loss of suppressive function. Conversely, children with coeliac disease show signs of CD101(+) /CD129(+) Treg cells that may indicate suppressor activity.
© 2014 British Society for Immunology.

Entities:  

Keywords:  T cytotoxic cells; T helper cells; T regulatory cells; coeliac disease; type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25421756      PMCID: PMC4367095          DOI: 10.1111/cei.12559

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  Cytokine profile in coeliac disease.

Authors:  N Lahat; S Shapiro; A Karban; R Gerstein; A Kinarty; A Lerner
Journal:  Scand J Immunol       Date:  1999-04       Impact factor: 3.487

2.  Generalized multi-organ autoimmunity in CCR7-deficient mice.

Authors:  Ana C M Davalos-Misslitz; Julia Rieckenberg; Stefanie Willenzon; Tim Worbs; Elisabeth Kremmer; Günter Bernhardt; Reinhold Förster
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

5.  Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis.

Authors:  K L Summers; J L O'Donnell; D N Hart
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

7.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

8.  Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.

Authors:  Weiting Du; Yueh-Wei Shen; Wen-Hui Lee; Ding Wang; Sachiko Paz; Fouad Kandeel; Chih-Pin Liu
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

9.  Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people.

Authors:  Sven Koch; Anis Larbi; Evelyna Derhovanessian; Dennis Ozcelik; Elissaveta Naumova; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-07-25       Impact factor: 6.400

10.  Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients.

Authors:  Marieke A van Leeuwen; M Fleur du Pré; Roy L van Wanrooij; Lilian F de Ruiter; H Rolien C Raatgeep; Dicky J Lindenbergh-Kortleve; Chris J Mulder; Lissy de Ridder; Johanna C Escher; Janneke N Samsom
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

View more
  6 in total

1.  Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.

Authors:  Cini R James; Irina Buckle; Franziska Muscate; Masayuki Otsuka; Mari Nakao; Jack Sh Oon; Raymond J Steptoe; Ranjeny Thomas; Emma E Hamilton-Williams
Journal:  Immunol Cell Biol       Date:  2016-01-14       Impact factor: 5.126

2.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  A1 and A2A adenosine receptors play a protective role to reduce prevalence of autoimmunity following tissue damage.

Authors:  Reut Riff; Oshri Naamani; Julia Mazar; Yosef S Haviv; Cidio Chaimovitz; Amos Douvdevani
Journal:  Clin Exp Immunol       Date:  2021-06-02       Impact factor: 5.732

4.  Nucleotide substitutions in CD101, the human homolog of a diabetes susceptibility gene in non-obese diabetic mouse, in patients with type 1 diabetes.

Authors:  Misako Okuno; Yoshihito Kasahara; Masafumi Onodera; Noriyuki Takubo; Michiko Okajima; Shigeru Suga; Nobuyuki Watanabe; Junichi Suzuki; Tadayuki Ayabe; Tatsuhiko Urakami; Tomoyuki Kawamura; Nobuyuki Kikuchi; Ichiro Yokota; Toru Kikuchi; Shin Amemiya; Kazuhiko Nakabayashi; Keiko Hayashi; Kenichiro Hata; Yoichi Matsubara; Tsutomu Ogata; Maki Fukami; Shigetaka Sugihara
Journal:  J Diabetes Investig       Date:  2016-11-25       Impact factor: 4.232

Review 5.  Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity.

Authors:  Marta Vuerich; Rasika P Harshe; Simon C Robson; Maria Serena Longhi
Journal:  Int J Mol Sci       Date:  2019-01-27       Impact factor: 5.923

Review 6.  Shigella Outer Membrane Vesicles as Promising Targets for Vaccination.

Authors:  Muhammad Qasim; Marius Wrage; Björn Nüse; Jochen Mattner
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.